BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20585569)

  • 1. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
    Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
    PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
    PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T; Bhattacharyya A
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
    de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
    Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
    de Sousa LP; de Almeida RF; Ribeiro-Gomes FL; de Moura Carvalho LJ; E Souza TM; de Souza DOG; Daniel-Ribeiro CT
    Parasit Vectors; 2018 Mar; 11(1):191. PubMed ID: 29554958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
    Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
    Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating experimental cerebral malaria using oxidative stress indicator OKD48 mice.
    Imai T; Iwawaki T; Akai R; Suzue K; Hirai M; Taniguchi T; Okada H; Hisaeda H
    Int J Parasitol; 2014 Sep; 44(10):681-5. PubMed ID: 24995619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
    Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
    Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria.
    Dai M; Reznik SE; Spray DC; Weiss LM; Tanowitz HB; Gulinello M; Desruisseaux MS
    Microbes Infect; 2010 Dec; 12(14-15):1198-207. PubMed ID: 20800692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Malaria Causes Enduring Behavioral and Molecular Changes in Mice Brain Without Causing Gross Histopathological Damage.
    Souza TL; Grauncke ACB; Ribeiro LR; Mello FK; Oliveira SM; Brant F; Machado FS; Oliveira MS
    Neuroscience; 2018 Jan; 369():66-75. PubMed ID: 29113928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA.
    Desruisseaux MS; Gulinello M; Smith DN; Lee SC; Tsuji M; Weiss LM; Spray DC; Tanowitz HB
    J Infect Dis; 2008 Jun; 197(11):1621-7. PubMed ID: 18419550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
    Canavese M; Crisanti A
    Pathog Glob Health; 2015 Sep; 109(6):266-74. PubMed ID: 26392164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.
    Dai M; Freeman B; Shikani HJ; Bruno FP; Collado JE; Macias R; Reznik SE; Davies P; Spray DC; Tanowitz HB; Weiss LM; Desruisseaux MS
    PLoS One; 2012; 7(10):e44117. PubMed ID: 23082110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Tocopheryl succinate-suppressed development of cerebral malaria in mice.
    Kume A; Kasai S; Furuya H; Suzuki H
    Parasitol Res; 2018 Oct; 117(10):3177-3182. PubMed ID: 30030625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
    Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
    PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune characteristics of
    Wang Y; Yao X; Tang MY; Liu L; Song SH; Tao ZY; Xia H; Chang XL; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Nov; 32(6):569-576. PubMed ID: 33325190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice.
    Herbas MS; Ueta YY; Ichikawa C; Chiba M; Ishibashi K; Shichiri M; Fukumoto S; Yokoyama N; Takeya M; Xuan X; Arai H; Suzuki H
    Malar J; 2010 Apr; 9():101. PubMed ID: 20403155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.